SCHEMBL402484

SCHEMBL402484

Cc1cccc(COC(=O)c2ccc(OC(=O)CCCc3ccc(NC(=O)c4ccc(C)nc4-c4ccc(C(F)(F)F)cc4)c(C(=O)N(C)C)c3)cc2)n1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 2/20 0.40
NTRK2 Q16620 1/20 0.40
PLK1 P53350 1/20 0.34
PPARG P37231 3/20 0.33
PPARA Q07869 3/20 0.33
PPARD Q03181 2/20 0.33
NR1H4 Q96RI1 1/20 0.33
HSPH1 Q92598 1/20 0.33
SORT1 Q99523 2/20 0.33
RXFP1 Q9HBX9 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
MTTP P55157 4/20 0.32
SUV39H1 O43463 1/20 0.32
EHMT2 Q96KQ7 1/20 0.32
PRMT1 Q99873 1/20 0.32
GCGR P47871 1/20 0.31
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL401089 0.92 NTRK1 (0.41) NTRK1NTRK2PLK1PPARGPPARA
SCHEMBL402266 0.92 NTRK1 (0.43) NTRK1NTRK2PLK1PPARGPPARA
SCHEMBL401986 0.91 MTTP (0.40) PPARGPPARAPPARDNR1H4RXFP1
SCHEMBL10205546 0.91 NTRK1 (0.42) NTRK1NTRK2PLK1PPARGPPARA
SCHEMBL403623 0.90 NTRK1 (0.39) NTRK1NTRK2KCNH2
SCHEMBL5318000 0.89 NTRK1 (0.43) NTRK1NTRK2PLK1PPARGPPARA
SCHEMBL401283 0.89 NTRK1 (0.40) NTRK1NTRK2PLK1PPARGPPARA
Sulfuric Acid SCHEMBL402780 0.86 NTRK1 (0.39) NTRK1NTRK2PLK1PPARGPPARA
SCHEMBL401345 0.85 NTRK1 (0.40) NTRK1NTRK2PPARGPPARAPPARD
SCHEMBL6091314 0.84 NTRK1 (0.41) NTRK1NTRK2PLK1PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP claimed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US claimed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA NTRK1 3420/4885NTRK2 2775/4885PLK1 4544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.